Hypermethylation of MDFI promoter with NSCLC is specific for females, non‑smokers and people younger than 65

Abstract

Non-small cell lung carcinoma (NSCLC) is a major subtype of lung cancer. Aberrant DNA methylation has been frequently observed in NSCLC. The aim of the present study was to investigate the role of MyoD family inhibitor (MDFI) methylation in NSCLC. Formalin-fixed paraffin-embedded tumor tissues and adjacent non-cancerous tissues were collected from a total of 111 patients with NSCLC. A methylation assay was performed using the quantitative methylation-specific polymerase chain reaction method. The percentage of methylated reference was used to represent the methylation level of the MDFI promoter. Data mining of a dataset from The Cancer Genome Atlas (TCGA) demonstrated that MDFI promoter methylation levels were significantly increased in 830 tumor tissues compared with 75 non-tumor tissues (P=0.012). However, the results on tissues obtained in the present study indicated that the MDFI promoter methylation levels in tumor tissues were not significantly different compared with those in the adjacent non-tumor tissues (P=0.159). Subsequent breakdown analysis identified that higher MDFI promoter methylation levels were significantly associated with NSCLC in females (P=0.031), but not in males (P=0.832). Age-based subgroup analysis demonstrated that higher MDFI promoter methylation levels were significantly associated with NSCLC in younger patients (≤65 years; P=0.003), but not in older patients (P=0.327). In addition, the association of MDFI methylation with NSCLC was significant in non-smokers (P=0.014), but not in smokers (P=0.832). Similar results also have been determined from subgroup analysis of the TCGA datasets. The Gene Expression Omnibus database indicated MDFI expression restoration in partial lung cancer cell lines (H1299 and Hotz) following demethylation treatment. However, it was identified that MDFI promoter hypermethylation was not significantly associated with prognosis of NSCLC (P>0.05). In conclusion, the present study indicated that the association of higher methylation of the MDFI promoter with NSCLC may be specific to females, non-smokers and people aged ≤65.

MicroRNA-296, a suppressor non-coding RNA, downregulates SGLT2 expression in lung cancer

“…Lung cancer does not have an exact cause, as some environmental factors, such as tobacco, radon, asbestos and other industrial carcinogens may increase the risk of developing lung cancer (8,35,36). NSCLC has a high incidence and high mortality, and has become the focus of research in recent years (37).…”

Epigenetic and genetic investigation of SOCS-1 gene in patients with multiple myeloma

“…Percent methylated reference (PMR) value of SOCS-1 in each sample was calculated using the 2-ΔΔCq method. ΔΔCq was calculated by subtracting the fully methylated DNA (Cq target gene-Cq ACTB control) from the sample DNA (Cq target gene-Cq ACTBcontrol) [ 18 ].…”